Bicara Therapeutics Inc. (BCAX)

NGM – Real Time Price. Currency in USD

25.03

+1.27 (5.37%)

Market open: Aug 12, 2026, 11:20 AM EDT

23.77

+0.01 (0.04%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-105K

-56K

-19K

-10K

Gross Profit

-105K

-56K

-19K

-10K

Operating expenses (excl. COGS)

-155M

-82M

-40M

-38M

Operating Income

-156M

-82M

-40M

-38M

Non-operating income, total

18M

15M

-12M

-188K

Pretax income

-138M

-68M

-52M

-38M

Equity in earnings

Taxes

-217K

-187K

-5K

-1K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-138M

-68M

-52M

-38M

Discontinued operations

Net income

-138M

-68M

-52M

-38M

Dilution adjustment

Preferred dividends

Bicara Therapeutics Inc. (BCAX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicara Therapeutics Inc. (BCAX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Bicara Therapeutics Inc. (BCAX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicara Therapeutics Inc. (BCAX)

Income Statement (Annual)

Income Statement (Annual)